Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Number To Know…30

Executive Summary

There are at least 30 US states with statutes that can protect cybersecurity whistleblowers.

In the US, there are more than 30 states with statutes on the books that can offer protection to cybersecurity whistleblowers in privately owned companies, including medical device firms. This is significant in light of the medtech industry moving increasingly into a world of connected products, and where cybersecurity issues with devices have arisen and are likely to persist. Whistleblowers of publicly traded companies can capitalize on a rewards program offered by the US Securities and Exchange.

To find out what incentives and initiatives are in place for individuals to raise the alarm on medtech companies falling foul of cybersecurity laws, click here for the Medtech Insight article.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104519

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel